Newedge-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
3,959
Total Value
16833614193
Accession Number
0001213900-25-043870
Form Type
13F-HR
Manager Name
Newedge-Advisors
Data Enrichment
66% identified
2,597 identified1,362 unidentified

Holdings

3,959 positions • $16.8B total value
Manager:
Search and click to pin securities to the top
Page 198 of 198
22nd Century Group, Inc.
Shares:2
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
LEXICON PHARMACEUTICALS, INC.
Shares:5
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
Nano Dimension Ltd.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
Skye Bioscience, Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
U S GLOBAL INVESTORS INC
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
LM FUNDING AMERICA, INC.
Shares:2
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
PodcastOne, Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
GERON CORP
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$16.8B)
Ovid Therapeutics Inc.
Shares:4
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
72303P404
Shares:4
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
62844N406
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
cbdMD, Inc.
Shares:5
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
150964104
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
Ascent Solar Technologies, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
XTI Aerospace, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
Matinas BioPharma Holdings, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$16.8B)
ORAGENICS INC
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$16.8B)
DIGITAL ALLY, INC.
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$16.8B)
Vaxart, Inc.
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$16.8B)